Kenneth L. Kehl

Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

Ino de Bruijn, Ritika Kundra, Brooke Mastrogiacomo et al. · Cancer Research · 2023 · 752 citations · Full text

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

Esther Aguilar, Biagio Ricciuti, Justin F. Gainor et al. · Annals of Oncology · 2019 · 318 citations

Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care

Kenneth L. Kehl, Mary Beth Landrum, Neeraj K. Arora et al. · JAMA Oncology · 2015 · 235 citations · Full text

Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer

Gideon M. Blumenthal, Yuexuan Gong, Kenneth L. Kehl et al. · Annals of Oncology · 2019 · 151 citations

Time-to-treatment Discontinuation, Medicine, Clinical Trials +10

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports

Kenneth L. Kehl, Haitham Elmarakeby, Mizuki Nishino et al. · JAMA Oncology · 2019 · 150 citations · Full text